NCT07421700: Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 132 planned
- Started
- 11 Mar 2026
- Primary completion
- 28 Dec 2027
- Arms
- Cohort B
- Results
- None posted
- 19 Feb 2026: Trial registered
- 11 Mar 2026: Trial started